Fig. 3
a and b Total numberof variants identified according to the clinical indication for analysis and corresponding ACMG classes. a the cohort is divided in two groups upon the specificity of the clinical suspicion, b: the “specific clinical suspicion” group was divided in two: “specific clinical suspicion other than connective tissue disorders” and “connective tissue disorders”